SUBSCRIBE
SUBSCRIBE
News   Drug Development

Lexicon Pharmaceuticals, Inc. Diabetes Drug Trial Shows Promise

September 16, 2009 | 
1 min read
Bookmark and Share

Reuters -- Lexicon Pharmaceuticals Inc said its experimental diabetes drug proved to be safe and well tolerated in an early stage study, driving its shares to more than double in value.
Clinical research Phase I
MORE ON THIS TOPIC
Creative collage image young man builder architect engineer occupation lungs healthcare illness disease drawing background.
Lung cancer
Merck, Daiichi Sankyo Stage Lung Cancer Rally With ‘Strong’ Pivotal Data for I-Dxd
September 8, 2025
 · 
2 min read
 · 
Tristan Manalac
graphic pattern with the tablet. topic of drugs. pill with girl and space inside. relax
Psychedelics
With Lykos MDMA Rejection Letter Out, MAPS Founder Decries ‘Change of the Goal Posts’
September 5, 2025
 · 
3 min read
 · 
Dan Samorodnitsky
Sanofi's Distribution Center in Quebec, Canada
Immunology and inflammation
Sanofi’s Anti-OX40 Blocker Falls ‘Well Below Expectations’ in Phase III Eczema Study
September 5, 2025
 · 
2 min read
 · 
Tristan Manalac
halftone magazine style banner, dislike, negative rating, hand thumbs down
FDA
FDA Drops Another Cache of Heavily Redacted Rejection Letters, Promises Future ‘Real-Time’ Access
September 4, 2025
 · 
4 min read
 · 
Annalee Armstrong